Related Experiment Video
Updated: Sep 16, 2025
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Evaluation of Retinal Inner Layer Thickness and its Relationship with Visual Prognosis in Multiple Sclerosis Patients
Kubra Kucukiba1, Gozde Orman1, Gulten Sungur1
1Department of Ophtalmology, Ankara Training and Research Hospital, Ankara, Türkiye.
Objectives:
The objective is to evaluate retinal inner layer thicknesses in multiple sclerosis (MS) patients with and without optic neuritis (ON) and investigate their relationship with visual prognosis.
Methods:
This cross-sectional retrospective study examined 120 MS patients (237 eyes), including 43 with unilateral ON and 26 with bilateral ON. Retinal layer measurements were obtained using Heidelberg Spectralis optical coherence tomography (OCT), including macular retinal nerve fiber layer, ganglion cell layer (GCL), inner plexiform layer (IPL), and peripapillary retinal nerve fiber layer (pRNFL) thicknesses across multiple quadrants defined by the Early Treatment Diabetic Retinopathy Study (ETDRS) grid.
Results:
Significant thinning was observed in GCL and IPL across all quadrants except the temporal region in ON patients. The 3 mm nasal GCL thickness showed the strongest correlation with visual acuity (r=0.725, p<0.001) in the ON group. IPL parameters demonstrated the second strongest correlation, with the 3 mm nasal region showing the highest correlation (r=0.675, p<0.001). While pRNFL showed significant thinning in all quadrants except the nasal quadrant in ON patients, it exhibited weaker correlations with visual acuity compared to GCL and IPL measurements.
Conclusion:
GCL and IPL measurements serve as more reliable and earlier biomarkers for visual prognosis in MS patients compared to pRNFL. The strongest structure-function relationships were observed in the 3 mm nasal and inferior quadrants of the ETDRS grid. These findings support the integration of OCT-based GCL and IPL thickness measurements into routine clinical practice for monitoring MS disease progression and treatment efficacy.
